Optimizing Ophthalmology Availity Integration for Prior Authorization

Klivira's ophthalmology Availity integration empowers eye care practices to automate and accelerate prior authorization workflows, connecting directly to a broad network of commercial payers.

For ophthalmology practices, managing prior authorizations for high-volume treatments like anti-VEGF injections, premium IOLs, and complex surgical procedures is a significant administrative challenge. Leveraging a multi-payer clearinghouse like Availity is critical for efficient submission and status tracking. Klivira streamlines this process, ensuring accurate and timely prior authorizations across the diverse payer landscape accessible through Availity.

The Intersection of Ophthalmology PA and Availity Workflows

Ophthalmology prior authorization is characterized by chronic treatment cycles and high-value procedures, making efficient submission crucial. Availity, as a multi-payer clearinghouse, provides a consolidated channel for submitting these authorizations to numerous commercial health plans, reducing the need for multiple payer portal logins. Klivira's integration optimizes this connection, ensuring that specialty-specific documentation requirements are met prior to submission.

Key Ophthalmology Procedures & Medications Requiring PA via Availity

Anti-VEGF intravitreal injections (e.g., Aflibercept, Ranibizumab, Faricimab) for conditions like wet AMD and DME.
Cataract surgery involving premium intraocular lenses (IOLs) or specific lens technologies.
Glaucoma surgical procedures, including micro-invasive glaucoma surgery (MIGS) and traditional approaches.
Corneal procedures such as DSAEK, DMEK, and corneal cross-linking for keratoconus.
Oculoplastic procedures like functional blepharoplasty for visual-field-affecting ptosis.

Streamlining Documentation for Availity Submissions

Ophthalmology PA often requires detailed clinical evidence, guided by frameworks like the AAO Preferred Practice Patterns. For anti-VEGF, this includes OCT findings, visual acuity, and prior treatment response. For functional blepharoplasty, visual field tests and photographs are essential. Klivira's platform automates the aggregation of these EMR-sourced documents, preparing them for seamless electronic submission through Availity's robust clearinghouse infrastructure.

Addressing Common Denial Reasons in Ophthalmology

Denials in ophthalmology frequently stem from issues like biosimilar substitution requirements for anti-VEGF, gaps in prior-treatment response documentation, or challenges in distinguishing cosmetic versus medical necessity for oculoplastic procedures. Klivira's Availity integration incorporates payer-specific policy logic to flag potential issues proactively, ensuring that submissions align with current guidelines and reducing the incidence of avoidable denials.

Optimizing EMR & Payer Touchpoints for Ophthalmology PA

Automated extraction of diagnostic imaging (OCT, FA) and visual acuity from EMRs.
Integration with EMR order sets for anti-VEGF injections and surgical procedures.
Electronic submission (ePA) of X12 278 requests and attachments via Availity.
Real-time status checks and communication through Availity's payer network.
Automated routing of biosimilar substitution requirements based on payer policy.

Klivira's Advantage in Ophthalmology Availity Integration

Klivira's platform is specifically engineered to navigate the complexities of ophthalmology prior authorization within the Availity ecosystem. By leveraging AAO-guideline-aware workflows, automating documentation for chronic anti-VEGF cycles, and applying logic for cosmetic-vs-medical determinations, Klivira ensures that eye care practices can process authorizations with unparalleled efficiency and accuracy, minimizing administrative burden and accelerating patient access to care.

Frequently asked questions

How does Klivira handle chronic anti-VEGF re-authorizations through Availity?

Klivira automates the re-authorization process for chronic anti-VEGF injections by tracking treatment cycles and prompting for necessary updated documentation, such as current OCT findings and visual acuity. This information is then compiled and submitted electronically via Availity, adhering to payer-specific re-authorization schedules.

Can Klivira's Availity integration help with premium IOL authorizations?

Yes, Klivira's Availity integration streamlines prior authorizations for premium IOLs. While standard cataract surgery is often exempt, premium lenses frequently require PA. Klivira helps ensure all necessary documentation, including medical necessity and patient acknowledgments, is correctly submitted through Availity's clearinghouse.

What EMR data does Klivira use for ophthalmology PA submissions via Availity?

Klivira extracts critical clinical data from your EMR, including diagnosis codes, procedure codes, visual acuity measurements, intraocular pressure (IOP) readings, visual field test results, and diagnostic imaging reports (e.g., OCT, fluorescein angiography). This comprehensive data populates the authorization requests submitted through Availity.

How does Klivira address biosimilar requirements for anti-VEGF drugs when submitting through Availity?

Klivira incorporates payer-specific policies regarding biosimilar substitution for anti-VEGF drugs. The platform intelligently routes authorization requests to align with these requirements, helping to prevent denials that arise from non-compliance with step therapy or preferred drug lists, all within the Availity submission framework.

Is Klivira's Availity integration compliant with HIPAA for ophthalmology PA?

Yes, Klivira's platform is designed with robust security measures and adheres to HIPAA regulations for protecting ePHI. All data transmitted through our Availity integration for ophthalmology prior authorizations is encrypted and handled securely, ensuring compliance with privacy standards.